Professor Wee Jo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS, is a Yong Loo Lin Professor in Medical Oncology and Vice Dean of Research at the Yong Loo Lin School of Medicine, National University of Singapore, where he is also a Senior Principal Investigator at the Cancer Science Institute of Singapore. He is concurrently the Director of the National University Cancer Institute, Singapore and the Group Director of Research, at the National University Health System.
Professor Chng currently serves as Executive Director of the Singapore Translational Cancer Consortium. His research focuses on the use of global genomics methods (microarray and sequencing platforms) to study the clinical and biological heterogeneity in haematologic malignancies including acute myeloid leukemia, multiple myeloma and lymphoma. Using these methods, he has identified novel prognostic markers and molecular abnomalities in these malignancies, serving as potential targets for therapy and providing insights into disease pathogenesis and biology. He has strong research interest in risk stratification and clinical trials in myeloma.
Professor Chng is a member of many international professional committees, such as the International Myeloma Working Group and the Asian Myeloma Network. He is also involved in a number of Grant Review Committees, Conference Organising Committees, Advisory Boards and the Steering Committees of Global Clinical Trials. He has authored more than 300 publications in many reputed journals, and actively participates in clinical trials, and has delivered talks at many national and international conferences. He has won multiple awards for his outstanding achievements in translational research both locally and internationally including the NUHS Research Excellence Award, the International Myeloma Foundation's Brian GM Durie Outstanding Achievement Award, the National Medical Excellence Outstanding Clinician Scientist Award, the National Medical Research Council Senior Translational Research (STaR) Award, the National University of Singapore Young Research Award, and the Celgene Future Leaders in Haematology Award.